THIS MESSAGE (MATERIAL) IS CREATED AND (OR) DISTRIBUTED BY A FOREIGN MASS MEDIA PERFORMING THE FUNCTIONS OF A FOREIGN AGENT AND (OR) A RUSSIAN LEGAL ENTITY PERFORMING THE FUNCTIONS OF A FOREIGN AGENT.
Scientists at Harvard University have “calculated” a disease that, according to them, immediately increases the risk of developing multiple sclerosis by 32 times.
Experts have found that the greatest influence on the possibility of an incurable neurological condition is infectious mononucleosis. It is caused by the Epstein-Barr virus, which is present in almost 80% of the world’s population, Lenta.ru reports.
At the same time, American scientists emphasize, the presence of other infections did not adversely affect the development of multiple sclerosis.
Recall also, earlier researchers from the University of Rochester came to the conclusion that a drug for multiple sclerosis can reduce the symptom of memory loss in Alzheimer’s disease. Scientists conducted experiments on transgenic mice, which by the age of 12 months develop symptoms characteristic of Alzheimer’s disease. The rodents were given subcutaneous injections of glatiramer acetate, which is used to treat multiple sclerosis.
After 8 weeks, the scientists tested the mice’s memory and analyzed the brain tissue. It turned out that mice treated with therapy retain memory better than those who did not receive the drug. The study of brain tissue also showed a reduction in the symptoms of Alzheimer’s disease.
Source: Rosbalt
Tristin is an accomplished author and journalist, known for his in-depth and engaging writing on sports. He currently works as a writer at 247 News Agency, where he has established himself as a respected voice in the sports industry.
